These studies indicate that IL-17A, GM-CSF and TGF-β can collaboratively induce monocytes-to-FABP5+ SAM differentiation and promote pathogenic collagen deposition by mesenchymal cells in IPF and NASH patients (65). This evidence concerns the gene IL17A and metabolic dysfunction-associated steatohepatitis.